Related Experiment Video
Updated: Jul 1, 2025
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
15.8K
Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer
Amit Kumar1, Akshay Kumar Lunawat1, Ashutosh Kumar1
1Department of Pharmaceutics, ISF College of Pharmacy, Moga, 142001, Punjab, India.
AAPS Pharmscitech
|March 6, 2024
Summary
Nanoparticle drug delivery systems offer improved prostate cancer treatment by enhancing drug solubility, circulation time, and targeted delivery. These innovations aim to reduce toxicity and improve therapeutic outcomes for patients.
Area of Science:
- Oncology
- Nanotechnology
- Drug Delivery
Background:
- Prostate cancer is a major global health issue.
- Conventional chemotherapy has limitations in efficacy and toxicity.
- Nanoparticle-based systems present a promising alternative for prostate cancer treatment.
Purpose of the Study:
- To review nanoparticle applications in prostate cancer therapy.
- To highlight advancements in nanocarrier drug delivery systems.
- To discuss the potential for clinical translation of these technologies.
Main Methods:
- Review of current literature on nanoparticle drug delivery for prostate cancer.
- Analysis of nanocarrier advantages: improved solubility, circulation, and targeting.
- Discussion of mechanisms including controlled release and site-specific accumulation.
Main Results:
- Nanoparticles enhance drug delivery to prostate cancer cells.
- Functionalized nanocarriers enable targeted accumulation in the tumor microenvironment.
- Controlled release kinetics reduce systemic toxicity and maintain efficacy.
Conclusions:
- Nanocarrier-based systems show significant potential for improving prostate cancer treatment outcomes.
- Further research and clinical trials are essential for validating these innovative drug delivery systems.
- The goal is to translate nanocarrier advancements into future clinical applications for prostate cancer therapy.
